Skip to content

Study on palatability of carboxysteine oral solution

Study on palatability of carboxysteine oral solution

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041778
Enrollment
Unknown
Registered
2021-01-05
Start date
2020-12-28
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beijing Children's Hospital, Capital Medical University

Interventions

Trial group:Carbocisteine Oral Solution (Chengji Pharm)
control group:Carbocisteine Oral Solution (Baiyunshan Pharm)

Sponsors

Beijing Children's Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 12 Years

Inclusion criteria

Inclusion criteria: (1) Normal temperature; (2) Children with bronchitis or bronchial asthma accompanied by sticky sputum and difficulty in coughing; (3) Phased treatment has been completed, and before discharge.

Exclusion criteria

Exclusion criteria: (1) Cannot eat normally or has dysphagia; (2) Self-reported impaired taste function; (3) Those who are allergic to the oral solution of carboxymestein or have an allergic constitution; (4) Patients with active gastrointestinal ulcer; (5) Persons with mental disorders who cannot correctly express their sense of reality; (6) being treated with a drug that may have contraindicated compatibility with the experimental drug; (7) Have any children unfit to participate in this experiment.

Design outcomes

Primary

MeasureTime frame
palatability;

Secondary

MeasureTime frame
facial expression;subjective assessment;safety;

Countries

China

Contacts

Public ContactXiaoling Wang, Xiaoxia Peng

Beijing Children's Hospital, Capital Medical University

pengxiaoxia@bch.com.cn+86 13370115075, +86 13681009489

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026